Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polidocanol vs Glucose for Telangiectasia Sclerotherapy
NCT02657252Phase 4Completed
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina de Botucatu
- Start
- Jan 2015
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of 10XB101 in telangiectasia, sponsored by Hospital das Clínicas da Faculdade de Medicina de Botucatu. Started Jan 2015; status: completed.
02
Drugs
10XB101
03
Conditions
telangiectasia
Beyond the preview
Go deeper on NCT02657252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02657252.